Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

The scientist who was jailed for three years for performing illegal gene-altering on babies has criticized ethics for slowing ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Scientists discovered genes in the tuberculosis bacterium that becomes essential for the pathogen's survival when it's exposed to air through coughing. These genes could be targets for new therapies ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced new findings from the ...

One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

“Ukraine is not yet dead.” These were the words we translated from the Ukrainian national anthem. We were young Peace Corps ...